226 related articles for article (PubMed ID: 16999659)
1. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.
Fardoun RZ
Pharmacotherapy; 2006 Oct; 26(10):1491-500. PubMed ID: 16999659
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
[TBL] [Abstract][Full Text] [Related]
3. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
Bell DS; Bakris GL; McGill JB
Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli F; Phillips RA; Raskin P; Wright JT; Waterhouse B; Lukas MA; Anderson KM; Bell DS;
Hypertension; 2005 Dec; 46(6):1309-15. PubMed ID: 16286578
[TBL] [Abstract][Full Text] [Related]
5. beta-blocker use and diabetes symptom score: results from the GEMINI study.
McGill JB; Bakris GL; Fonseca V; Raskin P; Messerli FH; Phillips RA; Katholi RE; Wright JT; Iyengar M; Anderson KM; Lukas MA; Dalal MR; Bell DS
Diabetes Obes Metab; 2007 May; 9(3):408-17. PubMed ID: 17391169
[TBL] [Abstract][Full Text] [Related]
6. Body weight changes with beta-blocker use: results from GEMINI.
Messerli FH; Bell DS; Fonseca V; Katholi RE; McGill JB; Phillips RA; Raskin P; Wright JT; Bangalore S; Holdbrook FK; Lukas MA; Anderson KM; Bakris GL;
Am J Med; 2007 Jul; 120(7):610-5. PubMed ID: 17602935
[TBL] [Abstract][Full Text] [Related]
7. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Wright JT; Bakris GL; Bell DS; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Holdbrook FK; Lukas MA; Iyengar M
J Clin Hypertens (Greenwich); 2007 Nov; 9(11):842-9. PubMed ID: 17978591
[TBL] [Abstract][Full Text] [Related]
8. The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
Bakris GL; Bell DS; Fonseca V; Katholi R; McGill J; Phillips R; Raskin P; Wright JT; Iyengar M; Holeslaw T; Anderson KM;
J Diabetes Complications; 2005; 19(2):74-9. PubMed ID: 15745836
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol in hypertension treatment.
Stafylas PC; Sarafidis PA
Vasc Health Risk Manag; 2008; 4(1):23-30. PubMed ID: 18629377
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
Fonseca V; Bakris GL; Bell DS; McGill JB; Raskin P; Messerli FH; Phillips RA; Katholi RE; Wright JT; Waterhouse B; Lukas MA; Anderson KM;
Diabet Med; 2007 Jul; 24(7):759-63. PubMed ID: 17451422
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
DiNicolantonio JJ; Hackam DG
Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523
[TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
Bank AJ; Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM
Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.
Jawa A; Nachimuthu S; Pendergrass M; Asnani S; Fonseca V
J Diabetes Complications; 2008; 22(5):303-8. PubMed ID: 18413195
[TBL] [Abstract][Full Text] [Related]
14. Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension.
Sica DA
J Clin Hypertens (Greenwich); 2005 Jan; 7(1):59-64. PubMed ID: 15655391
[No Abstract] [Full Text] [Related]
15. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.
Fonseca V; Sharma PP; Shah M; Deedwania P
Curr Med Res Opin; 2011 Apr; 27(4):799-807. PubMed ID: 21306286
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile.
Bakris GL; Tarka EA; Waterhouse B; Goulding MR; Madan A; Anderson KM; St John Sutton M; Miller AB; Reichek N
Am J Cardiol; 2006 Oct; 98(7A):46L-52L. PubMed ID: 17023232
[TBL] [Abstract][Full Text] [Related]
17. Use of carvedilol in hypertension: an update.
Leonetti G; Egan CG
Vasc Health Risk Manag; 2012; 8():307-22. PubMed ID: 22661898
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
[TBL] [Abstract][Full Text] [Related]
20. Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
Phillips RA; Fonseca V; Katholi RE; McGill JB; Messerli FH; Bell DS; Raskin P; Wright JT; Iyengar M; Anderson KM; Lukas MA; Bakris GL;
J Cardiometab Syndr; 2008; 3(4):211-7. PubMed ID: 19040589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
